The Life Sciences Report

"DRIO is developing a very interesting approach to diagnostics at the level of data capture." (12/5/13) LabStyle Innovations Corp. - The Life Sciences Report Interview with Ram Selvaraju More >

"CPRX has a few programs in indications that are less crowded and do not have many successful treatment options." (11/26/13) Catalyst Pharmaceutical Partners Inc. - The Life Sciences Report Interview with Michael Hay More >

"ATHX's MultiStem phase 2 data are going to be very important for investors if the trial is positive for patients." (11/26/13) Athersys Inc. - The Life Sciences Report Interview with Michael Hay More >

"CYTX's ADRC product has been approved for breast reconstruction in Europe." (11/26/13) Cytori Therapeutics Inc. - The Life Sciences Report Interview with Michael Hay More >

"We expect FDA approval in the near term—likely by the end of the year—for OCLS' Microcyn Hydrogel device." (11/26/13) Oculus Innovative Sciences Inc. - The Life Sciences Report Interview with Jocelyn August More >